Telix Pharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 564.76 K | $5.40 M | 357.03% | 0.17% |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 05/15/2026 | 541.27 K | $5.18 M | 100.00% | 0.16% |
| LAZARD ASSET MANAGEMENT LLC | 05/15/2026 | 289.92 K | $2.77 M | 15.73% | 0.09% |
| PORTLAND INVESTMENT COUNSEL INC. | 05/14/2026 | 266.20 K | $2.55 M | 0.00% | 0.08% |
| PRIVATE ADVISOR GROUP, LLC | 04/27/2026 | 174.42 K | $1.67 M | 276.34% | 0.05% |
| INTEGRATED WEALTH CONCEPTS LLC | 05/15/2026 | 164.40 K | $1.57 M | 100.00% | 0.05% |
| RAIFFEISEN BANK INTERNATIONAL AG | 04/24/2026 | 130.00 K | $1.16 M | 100.00% | 0.04% |
| MORGAN STANLEY | 05/15/2026 | 116.44 K | $1.11 M | 559.60% | 0.03% |
| JPMORGAN CHASE & CO | 05/13/2026 | 57.35 K | $513.84 K | -22.89% | 0.02% |
| MARINER, LLC | 05/13/2026 | 43.45 K | $415.34 K | 18.76% | 0.01% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 34.87 K | $333.73 K | 100.00% | 0.01% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 05/14/2026 | 33.25 K | $318.23 K | 83.30% | 0.01% |
| UBS GROUP AG | 05/05/2026 | 32.30 K | $309.11 K | 1,544.60% | 0.01% |
| XTX TOPCO LTD | 05/15/2026 | 26.01 K | $248.89 K | 120.03% | 0.01% |
| IHT WEALTH MANAGEMENT, LLC | 05/15/2026 | 25.04 K | $239.59 K | -0.99% | 0.01% |
| VIDENT ADVISORY, LLC | 05/15/2026 | 16.65 K | $159.37 K | -38.89% | 0.00% |
| XY CAPITAL LTD | 05/12/2026 | 12.55 K | $120.12 K | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 12.00 K | $114.84 K | 700.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 10.03 K | $96.00 K | 523.82% | 0.00% |
| RHUMBLINE ADVISERS | 05/12/2026 | 9.82 K | $94.00 K | -8.94% | 0.00% |
| NEWEDGE ADVISORS, LLC | 06/03/2026 | 1.92 K | $18.37 K | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 05/18/2026 | 1.83 K | $17.53 K | 104.01% | 0.00% |
| CWM, LLC | 05/14/2026 | 1.43 K | $13.64 K | 100.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 05/15/2026 | 899 | $8.60 K | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 756 | $7.24 K | 140.76% | 0.00% |
| RONALD BLUE TRUST, INC. | 04/20/2026 | 742 | $7.10 K | -75.96% | 0.00% |
| ASPECT PARTNERS, LLC | 04/02/2026 | 380 | $3.64 K | 7.95% | 0.00% |
| BLACKROCK, INC. | 05/13/2026 | 352 | $3.37 K | 300.00% | 0.00% |
| ASSETMARK, INC | 05/06/2026 | 153 | $1.46 K | 240.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 04/29/2026 | 127 | $1.22 K | 100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 05/13/2026 | 125 | $9.86 K | -88.46% | 0.00% |
| BELL INVESTMENT ADVISORS, INC | 04/17/2026 | 70 | $670 | 100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 04/30/2026 | 65 | $622 | 100.00% | 0.00% |
| MV CAPITAL MANAGEMENT, INC. | 04/30/2026 | 61 | $584 | 454.55% | 0.00% |
| SMARTLEAF ASSET MANAGEMENT LLC | 05/15/2026 | 37 | $332 | -48.61% | 0.00% |
| TRANSAMERICA FINANCIAL ADVISORS, INC. | 05/15/2026 | 28 | $267 | 12.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 9 | $83 | 0.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 06/03/2026 | 1 | $13 | -91.67% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| OLD MISSION CAPITAL LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| QUADRATURE CAPITAL LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| INDEPENDENCE BANK OF KENTUCKY | 04/30/2026 | 0 | $0 | -100.00% | 0.00% |
| TRUE WEALTH DESIGN, LLC | 04/13/2026 | 0 | $0 | -100.00% | 0.00% |
| 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
Telix Pharmaceuticals Ltd. institutional Ownership - FAQ's
During the previous two years, 48 institutional investors and hedge funds held shares of Telix Pharmaceuticals Ltd.. The most heavily invested institutionals were:
FMR LLC: 564,757
Portolan Capital Management, LLC: 541,267
LAZARD ASSET MANAGEMENT LLC: 289,917
PORTLAND INVESTMENT COUNSEL INC.: 266,200
Private Advisor Group, LLC: 174,415
Integrated Wealth Concepts LLC: 164,397
0.76% of Telix Pharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 2.57 M shares in the last 24 months. This purchase volume represents approximately $19.25 M in transactions.